Skip to main content

Table 2 Rmax, pIC30 and pIC50 of propofol on rat pulmonary and aorta and on human pulmonary artery precontracted by KCl and PHE

From: Effect of propofol and etomidate on normoxic and chronically hypoxic pulmonary artery

  

Rmax (%control)

pIC30 (M)

pIC50 (M)

n

normoxic rat PA

KCl

94.0 ± 2.3*°

4.69 ± 0.14*‡°

4.35 ± 0.14‡°

7

 

PHE

46.1 ± 9.1†

3.54 ± 0.26†

1.96 ± 0.76†

7

human PA

KCl

66.5 ± 11.8

3.69 ± 0.16‡

3.01 ± 0.30‡

7

 

PHE

51.6 ± 15.0

3.33 ± 0.34

3.00 ± 0.49

7

CH rat PA

KCl

127.4 ± 15.9

4.83 ± 0.17

4.49 ± 0.17

9

 

PHE

90.1 ± 11.7

4.30 ± 0.17

3.86 ± 0.23

6

normoxic rat aorta

KCl

79.9 ± 5.3*

4.32 ± 0.10*

3.89 ± 0.14*

9

 

PHE

48.1 ± 5.3†

3.53 ± 0.14

2.69 ± 0.38

7

CH rat aorta

KCl

101.3 ± 16.7

4.45 ± 0.10

4.15 ± 0.11

8

 

PHE

73.1 ± 5.0

4.09 ± 0.24

3.61 ± 0.20

6

  1. Mean maximal relaxation to propofol (Rmax, % control), and mean 50% and 30% maximal contraction inhibitory concentrations (pIC50 and pIC30, M) in pulmonary artery (PA) and aorta from normoxic and chronically hypoxic (CH) rat and in human pulmonary artery precontracted with 100 mM KCl (KCl) and 10-6 M phenylephrine (PHE). Rmax, pIC50 and pIC30 values are mean ± SEM. *P < 0.05 KCl versus PHE; †P < 0.05 normoxic versus HC tissues; ‡P < 0.05 rat PA versus Human PA; °P < 0.05 PA versus aorta.